HYDROMORPHONE HYDROCHLORIDE au Canada
86 fiches de médicaments provenant de 15 titulaires portent ce nom dans les sources officielles. Collectées le 16 novembre 2026.
Médicaments
| Nom | Titulaire | Statut | Code |
|---|---|---|---|
| APO-HYDROMORPHONE · 1 MG · TABLET | APOTEX INC | authorised |
DIN
02364115Code de médicament DPD
84905
|
| APO-HYDROMORPHONE · 2 MG · TABLET | APOTEX INC | authorised |
DIN
02364123Code de médicament DPD
84906
|
| APO-HYDROMORPHONE · 4 MG · TABLET | APOTEX INC | authorised |
DIN
02364131Code de médicament DPD
84907
|
| APO-HYDROMORPHONE · 8 MG · TABLET | APOTEX INC | authorised |
DIN
02364158Code de médicament DPD
84908
|
| APO-HYDROMORPHONE CR · 12 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476657Code de médicament DPD
96750
|
| APO-HYDROMORPHONE CR · 18 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476665Code de médicament DPD
96751
|
| APO-HYDROMORPHONE CR · 24 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476673Code de médicament DPD
96752
|
| APO-HYDROMORPHONE CR · 30 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476681Code de médicament DPD
96753
|
| APO-HYDROMORPHONE CR · 3 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476614Code de médicament DPD
96746
|
| APO-HYDROMORPHONE CR · 4.5 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476622Code de médicament DPD
96747
|
| APO-HYDROMORPHONE CR · 6 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476630Code de médicament DPD
96748
|
| APO-HYDROMORPHONE CR · 9 MG · CAPSULE (EXTENDED-RELEASE) | APOTEX INC | authorised |
DIN
02476649Code de médicament DPD
96749
|
| BAR-HYDROMORPHONE CR · 12 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460815Code de médicament DPD
94830
|
| BAR-HYDROMORPHONE CR · 18 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460823Code de médicament DPD
94831
|
| BAR-HYDROMORPHONE CR · 24 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460831Code de médicament DPD
94832
|
| BAR-HYDROMORPHONE CR · 30 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460858Code de médicament DPD
94833
|
| BAR-HYDROMORPHONE CR · 3 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460777Code de médicament DPD
94826
|
| BAR-HYDROMORPHONE CR · 4.5 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460785Code de médicament DPD
94827
|
| BAR-HYDROMORPHONE CR · 6 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460793Code de médicament DPD
94828
|
| BAR-HYDROMORPHONE CR · 9 MG · CAPSULE (EXTENDED-RELEASE) | BARD PHARMACEUTICALS (1990) INC | cancelled |
DIN
02460807Code de médicament DPD
94829
|
| DILAUDID · 1 MG per ML · LIQUID | PURDUE PHARMA | cancelled |
DIN
00786535Code de médicament DPD
10173
|
| DILAUDID · 1 MG · TABLET | PURDUE PHARMA | authorised |
DIN
00705438Code de médicament DPD
6889
|
| DILAUDID · 250 MG per VIAL · POWDER FOR SOLUTION | PURDUE PHARMA | cancelled |
DIN
02085895Code de médicament DPD
16679
|
| DILAUDID · 2 MG per ML · LIQUID | PURDUE PHARMA | cancelled |
DIN
00627100Code de médicament DPD
5937
|
| DILAUDID · 2 MG · TABLET | PURDUE PHARMA | authorised |
DIN
00125083Code de médicament DPD
5939
|
| DILAUDID · 3 MG · SUPPOSITORY | PURDUE PHARMA | cancelled |
DIN
00125105Code de médicament DPD
5938
|
| DILAUDID · 4 MG · TABLET | PURDUE PHARMA | authorised |
DIN
00125121Code de médicament DPD
5940
|
| DILAUDID · 8 MG · TABLET | PURDUE PHARMA | authorised |
DIN
00786543Code de médicament DPD
9509
|
| DILAUDID HP · 10 MG per ML · LIQUID | PURDUE PHARMA | cancelled |
DIN
00622133Code de médicament DPD
5936
|
| DILAUDID-HP-PLUS · 20 MG per ML · SOLUTION | PURDUE PHARMA | cancelled |
DIN
02146118Code de médicament DPD
17822
|
| DILAUDID-XP · 50 MG per ML · LIQUID | PURDUE PHARMA | cancelled |
DIN
02145863Code de médicament DPD
17823
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG · 12 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02125366Code de médicament DPD
20171
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG · 18 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02243562Code de médicament DPD
67480
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG · 24 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02125382Code de médicament DPD
20172
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG · 30 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02125390Code de médicament DPD
43838
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG · 3 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02125323Code de médicament DPD
18556
|
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG · 6 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02125331Code de médicament DPD
18558
|
| HYDROMORPH CONTIN · CONTROLLED-RELEASE CAPSULE · 4.5 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02359502Code de médicament DPD
84452
|
| HYDROMORPH CONTIN · CONTROLLED-RELEASE CAPSULE · 9 MG · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02359510Code de médicament DPD
84453
|
| HYDROMORPH.IR - 2MG · 2 MG · TABLET | PURDUE PHARMA | cancelled |
DIN
02245703Code de médicament DPD
69806
|
| HYDROMORPH.IR - 4MG · 4 MG · TABLET | PURDUE PHARMA | cancelled |
DIN
02245704Code de médicament DPD
69807
|
| HYDROMORPH.IR - 8MG · 8 MG · TABLET | PURDUE PHARMA | cancelled |
DIN
02245705Code de médicament DPD
69808
|
| HYDROMORPHONE · 1 MG · TABLET | SORRES PHARMA INC | cancelled |
DIN
02192101Code de médicament DPD
35655
|
| HYDROMORPHONE · 2 MG · TABLET | SORRES PHARMA INC | cancelled |
DIN
02249928Code de médicament DPD
73474
|
| HYDROMORPHONE · 4 MG · TABLET | SORRES PHARMA INC | cancelled |
DIN
02249936Code de médicament DPD
73475
|
| HYDROMORPHONE · 8 MG · TABLET | SORRES PHARMA INC | cancelled |
DIN
02192144Code de médicament DPD
35658
|
| HYDROMORPHONE HCL TAB 2MG USP · 2 MG · TABLET | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | cancelled |
DIN
01916289Code de médicament DPD
12596
|
| HYDROMORPHONE HCL TAB 4MG USP · 4 MG · TABLET | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | cancelled |
DIN
01916270Code de médicament DPD
12595
|
| HYDROMORPHONE HP 10 · 10 MG per ML · SOLUTION | SANDOZ CANADA INCORPORATED | authorised |
DIN
02145928Code de médicament DPD
18323
|
| HYDROMORPHONE HP 20 · 20 MG per ML · SOLUTION | SANDOZ CANADA INCORPORATED | authorised |
DIN
02145936Code de médicament DPD
18325
|
Besoin de cette liste dans votre propre système ?
Chaque fiche de cette page est disponible via l’API, avec sa source, sa licence et sa date de collecte.